Pyrimidine inhibitors of kinase activity
US8354422B2 · kind B2 · utility
1Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 2010 |
| Grant date | Jan 15, 2013 |
| Priority date | — |
| Expiry date | Jul 24, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts or solvates thereof,wherein G1, R2, R3, R4, R5, n, p, q, Ar1, and Ar2 are defined in the description. The present invention relates also to methods of making said compounds, and compositions comprising said compounds which are useful for inhibiting kinases such as IGF-1R.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.